IOVANCE BIOTHERAPEUTICS, INC.: 10-Q filed 2011-11-21

Name: IOVANCE BIOTHERAPEUTICS, INC.: 10-Q filed 2011-11-21
Creator: IOVANCE BIOTHERAPEUTICS, INC.

What IOVANCE BIOTHERAPEUTICS, INC. reported in its quarterly report filed 2011-11-21 (fiscal Q3 2011): 21 published measures, 65 facts as tagged in accession 0001144204-11-066214.

This filing

Form: 10-Q (quarterly report)
Filed: 2011-11-21
Fiscal period: fiscal Q3 2011
Accession: 0001144204-11-066214 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IOVANCE BIOTHERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2011-09-30	3,438,596	USD
At 2010-12-31	1,460,952	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2011-09-30	-5,690,725	USD
At 2010-12-31	638,085	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2011-09-30	910,608	USD
At 2010-12-31	1,292,469	USD
At 2010-09-30	795,943	USD
At 2009-12-31	8,257	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-5,818,478	USD	92
2011-01-01 to 2011-09-30	-17,342,514	USD	273
2007-09-17 to 2011-09-30	-19,024,990	USD	1475
2010-07-01 to 2010-09-30	-713,757	USD	92
2010-01-01 to 2010-09-30	-866,066	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-3,479,545	USD	273
2007-09-17 to 2011-09-30	-4,172,213	USD	1475
2010-01-01 to 2010-09-30	-251,213	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-20,316	USD	273
2007-09-17 to 2011-09-30	-24,316	USD	1475
2010-01-01 to 2010-09-30	-2,981	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	3,118,000	USD	273
2007-09-17 to 2011-09-30	5,107,137	USD	1475
2010-01-01 to 2010-09-30	1,041,880	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	-20,316	USD	273
2007-09-17 to 2011-09-30	-24,316	USD	1475
2010-01-01 to 2010-09-30	-2,981	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2011-09-30	-19,024,990	USD
At 2010-12-31	-1,682,476	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2011-09-30	18,803	USD
At 2010-12-31	0	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	8,010,000	USD	273
2007-09-17 to 2011-09-30	8,010,000	USD	1475
2010-01-01 to 2010-09-30	0	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-5,814,141	USD	92
2011-01-01 to 2011-09-30	-17,033,575	USD	273
2007-09-17 to 2011-09-30	-17,923,476	USD	1475
2010-07-01 to 2010-09-30	-167,027	USD	92
2010-01-01 to 2010-09-30	-319,336	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2011-09-30	3,298,108	USD
At 2010-12-31	1,300,916	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-31,644	USD	92
2011-01-01 to 2011-09-30	-31,644	USD	273
2007-09-17 to 2011-09-30	-31,644	USD	1475
2010-07-01 to 2010-09-30	0	USD	92
2010-01-01 to 2010-09-30	0	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2011-09-30	9,129,321	USD
At 2010-12-31	822,867	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2011-09-30	206,864	USD
At 2010-12-31	30,292	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	5,814,141	USD	92
2011-01-01 to 2011-09-30	17,033,575	USD	273
2007-09-17 to 2011-09-30	17,923,476	USD	1475
2010-07-01 to 2010-09-30	167,027	USD	92
2010-01-01 to 2010-09-30	319,336	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2011-09-30	73,638,349	shares
At 2010-12-31	73,638,349	shares

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2011-09-30	1,513	USD
At 2010-12-31	0	USD

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	-4,337	USD	92
2011-01-01 to 2011-09-30	-308,939	USD	273
2007-09-17 to 2011-09-30	-1,101,514	USD	1475
2010-07-01 to 2010-09-30	-546,730	USD	92
2010-01-01 to 2010-09-30	-546,730	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2011-01-01 to 2011-09-30	873,000	USD	273
2007-09-17 to 2011-09-30	2,844,000	USD	1475
2010-01-01 to 2010-09-30	1,065,000	USD	273

Inspect the source

Entity: IOVANCE BIOTHERAPEUTICS, INC. / CIK 0001425205
Captured: 2026-09-20T08:03:45.999Z
SEC response SHA-256: bb58496635d85ba57e1fe3f80d062d09fbf1db1b6d80eb6e8ba8eda9321f7680

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001425205.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))